Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients

Oral Oncology

Volumn 48, Issue 11, 2012, Pages 1171-1177

  Supic, Gordana ^a,b   Jovic, Nebojsa ^a,b   Zeljic, Katarina ^a,c   Kozomara, Ruzica ^a,b   Magic, Zvonko ^a,b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b University of Defense ^*  (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cancer risk; Haplotype; Head and neck squamous cell carcinoma; Oral squamous cell carcinoma; Overall survival; Polymorphisms; VEGF

Indexed keywords

VASCULOTROPIN A;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; ETHNICITY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; STRATIFIED SAMPLE;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867878360     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.05.023     Document Type: Article

References (44)

1. P.K. Tsantoulis, N.G. Kastrinakis, A.D. Tourvas, G. Laskaris, and V.G. Gorgoulis Advances in the biology of oral cancer Oral Oncol 43 2007 523 534
2. S. Johnstone, and R. Logan The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma Oral Oncol 42 2006 337 342
3. R. Roskoski Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression Crit Rev Oncol Hematol 62 2007 179 213
4. A. Hoeben, B. Landuyt, M.S. Highley, H. Wildiers, A. Van Oosterom, and E. De Bruijn Vascular endothelial growth factor and angiogenesis Pharmacol Rev 56 2004 549 580
5. S. Shintani, C. Li, T. Ishikawa, M. Mihara, K. Nakashiro, and H. Hamakawa Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma Oral Oncol 40 2004 13 20
6. M. Uehara, K. Sano, H. Ikeda, J. Sekine, A. Irie, and T. Yokota Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma Oral Oncol 40 2004 321 325
7. Z.J. Shang, J.R. Li, and Z.B. Li Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma J Oral Maxillofac Surg 65 2007 17 21
8. S. Seki, M. Fujiwara, M. Matsuura, S. Fujita, H. Ikeda, and I. Asahina Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors Oral Oncol 47 2011 588 593
9. I.J. Brogan, N. Khan, K. Isaac, J.A. Hutchinson, V. Pravica, and I.V. Hutchinson Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene Hum Immunol 60 1999 1245 1249
10. Q. Jin, K. Hemminki, K. Enquist, P. Lenner, E. Grzybowska, and R. Klaes Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis Clin Cancer Res 11 2005 3647 3653
11. W. Renner, S. Kotschan, C. Hoffmann, B. Obermayer-Pietsch, and E. Pilger A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels J Vasc Res 37 2000 443 448
12. T. Awata, K. Inoue, S. Kurihara, T. Ohkubo, M. Watanabe, and K. Inukai A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes Diabetes 51 2002 1635 1639
13. M. Mohammadi, W. Ollier, and I.V. Hutchinson A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated PBM cells Hum Immunol 64 2003 S125
14. M. Shahbazi, A.A. Fryer, V. Pravica, I.J. Brogan, H.M. Ramsay, I.V. Hutchinson, and P.N. Harden Polymorphisms in vascular endothelial growth factor gene is associated with increased risk of acute rejection in renal transplant recipients J Am Soc Nephrol 1 2002 260 264
15. D. Lambrechts, E. Storkebaum, and M. Morimoto VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death Nat Genet 34 2003 383 394
16. M.I. Koukourakis, D. Papazoglou, A. Giatromanolaki, G. Bougioukas, E. Maltezos, and E. Sivridis VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer Lung Cancer 46 2004 293 298
17. P. Krippl, U. Langsenlehner, W. Renner, B. Yazdani-Biuki, G. Wolf, and T.C. Wascher A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk Int J Cancer 106 2003 468 471
18. W. Howell, A. Bateman, S. Turner, A. Collins, and J. Theaker Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma Genes Immun 3 2002 229 232
19. S.L. McCarron, S. Edwards, P.R. Evans, R. Gibbs, D.P. Dearnaley, and A. Dowe Influence of cytokine gene polymorphisms on the development of prostate cancer Cancer Res 62 2002 3369 3372
20. M. Ruiz, P. Biselli, J. Maniglia, E. Pavarino-Bertelli, and E. Goloni-Bertollo Genetic variability of vascular endothelial growth factor and prognosis of head and neck cancer in a Brazilian population Braz J Med Biol Res 43 2010 127 133
21. P.A. Bradbury, R. Zhai, C. Ma, W. Xu, J. Hopkins, and M.J. Kulke Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis Clin Cancer Res 15 2009 4680 4685
22. Z.N. Unal, M. Unal, O.T. Bagdatoglu, G. Polat, and U. Atik Genetic polymorphism of VEGF-1154 (A/G) in laryngeal squamous cell carcinoma Arch Med Res 39 2008 209 211
23. C. Yapijakis, E. Vairaktaris, S. Vassiliou, A. Vylliotis, E. Nkenke, and A.M. Nixon The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer J Cancer Res Clin Oncol 133 2007 787 791
24. E. Vairaktaris, Z. Serefoglou, D. Avgoustidis, C. Yapijakis, E. Critselis, and A. Vylliotis Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer Oral Oncol 45 2009 247 253
25. P. Kämmerer, T. Toyoshima, S. Eletr, P. Kämmerer, K. Kuhr, and B. Al-Nawas Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma J Oral Pathol Med 39 2010 786 792
26. C.Y. Cheng, C.S. Chang, C.J. Liu, and S.Y. Kao Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 2008 79 84
27. C. Watson, N. Webb, M. Bottomley, and P. Brenchley Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production Cytokine 12 2000 1232 1235
28. G. Pages, and J. Pouyssegur Transcriptional regulation of the vascular endothelial growth factor gene - a concert of activating factors Cardiovasc Res 65 2005 564 573
29. I. Huez, S. Bornes, D. Bresson, L. Créancier, and H. Prats New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation Mol Endocrinol 15 2001 2197 2210
30. Y.F. Hu, B. Luscher, A. Admon, N. Mermod, and R. Tjian Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity Genes Dev 4 1990 1741 1752
31. L.H. Sobin, and C.H. Wittelind Union Internationale Contre le Cancer (UICC) International union against cancer: TNM classification of malignant tumours 6th ed. 2002 Wiley New York
32. P.N. Wahi, B. Cohen, U.K. Luthra, and H. Torloni Histological typing of oral and oropharyngeal tumours 1971 World Health Organization Geneva p. 17-18
33. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
34. D.A. Tregouet, and V. Garelle A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies Bioinformatics 23 2007 1038 1039
35. J. Seo, S. Lee, S. Kim, W. Ryu, K. Sa, and S. Kim Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis Rheumatology 44 2005 1299 1302
36. A. Koutras, A. Antonacopoulou, A. Eleftheraki, F. Dimitrakopoulos, A. Koumarianou, and I. Varthalitis Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab Pharmacogenomics J 2011 10.1038/tpj.2011.37
37. C.Y. Chien, C.Y. Su, C.F. Hwang, H.C. Chuang, C.M. Chen, and C.C. Huang High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis J Surg Oncol 94 2006 413 417
38. S.H. Kim, N.H. Cho, K. Kim, J.S. Lee, B.S. Koo, and J.H. Kim Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression J Surg Oncol 93 2006 330 337
39. C. Li, S. Shintani, N. Terakado, S. Klosek, T. Ishikawa, and K. Nakashiro Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas Int J Oral Maxillofac Surg 34 2005 559 565
40. A. Salajegheh, R.A. Smith, K. Kasem, V. Gopalan, M.R. Nassiri, and R. William Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes Eur J Surg Oncol 37 2011 93 99
41. S. Prior, J. Hagberg, C. Paton, L. Douglass, M. Brown, and J. McLenithan DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption Am J Physiol Heart Circ Physiol 290 2006 H1848 H1855
42. B.P. Schneider, M. Wang, M. Radovich, G.W. Sledge, S. Badve, and A. Thor Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100 J Clin Oncol 26 2008 4672 4678
43. V. Formica, R. Palmirotta, G. Del Monte, A. Savonarola, G. Ludovici, and M. De Marchis Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab Int J Colorectal Dis 26 2011 143 151
44. Y. Okada, H. Ueno, M. Katagiri, T. Oneyama, K. Shimomura, and S. Sakurai Experimental study of antiangiogenic gene therapy targeting VEGF in oral cancer Odontology 98 2010 52 59